制药公司 Lupin 任命 Abdelaziz Toumi 为其新子公司 Lupin Manufacturing Solutions (LMS) 的首席执行官。 Pharma firm Lupin appoints Abdelaziz Toumi as CEO of its new subsidiary, Lupin Manufacturing Solutions (LMS).

制药公司 Lupin 任命 Abdelaziz Toumi 为其新子公司 Lupin Manufacturing Solutions (LMS) 的首席执行官。 Pharma firm Lupin appoints Abdelaziz Toumi as CEO of its new subsidiary, Lupin Manufacturing Solutions (LMS). LMS 专注于活性药物成分的开发、制造和销售，并正在构建其合同开发和制造运营业务。 LMS focuses on the development, manufacture, and sale of Active Pharmaceutical Ingredients and is building its Contract Development and Manufacturing Operations business. Toumi 在生物技术、制药和 CDMO 领域拥有 20 多年的经验，足迹遍及欧洲、北美和亚洲。 Toumi brings 20+ years of experience in the biotech, pharma, and CDMO sectors, spanning Europe, North America, and Asia.